 According to European Guidelines, the preferred route of iron supplementation in IBD is intravenous. Absolute indications for intravenous iron include severe anaemia Hb 10 gdL. The current study is a part of a programme investigating the efficacy and safety of FERINJECT, a new formulation of parenteral iron 5 weight per volume iron containing ferric carboxymaltose in a solution of water for injection. 